Koprivica V - Search Results

1

The Nogo signaling pathway for regeneration block.

He Z, Koprivica V. He Z, et al. Among authors: koprivica v. Annu Rev Neurosci. 2004;27:341-68. doi: 10.1146/annurev.neuro.27.070203.144340. Annu Rev Neurosci. 2004. PMID: 15217336 Review.

2

Knowing how to navigate: mechanisms of semaphorin signaling in the nervous system.

He Z, Wang KC, Koprivica V, Ming G, Song HJ. He Z, et al. Among authors: koprivica v. Sci STKE. 2002 Feb 12;2002(119):re1. doi: 10.1126/stke.2002.119.re1. Sci STKE. 2002. PMID: 11842242 Review.

3

Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth.

Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z. Wang KC, et al. Among authors: koprivica v. Nature. 2002 Jun 27;417(6892):941-4. doi: 10.1038/nature00867. Epub 2002 Jun 16. Nature. 2002. PMID: 12068310

4

EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans.

Koprivica V, Cho KS, Park JB, Yiu G, Atwal J, Gore B, Kim JA, Lin E, Tessier-Lavigne M, Chen DF, He Z. Koprivica V, et al. Science. 2005 Oct 7;310(5745):106-10. doi: 10.1126/science.1115462. Science. 2005. PMID: 16210539

5

Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.

Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T. Jordan S, et al. Among authors: koprivica v. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):348-56. doi: 10.1016/j.pnpbp.2006.09.007. Epub 2006 Oct 27. Prog Neuropsychopharmacol Biol Psychiatry. 2007. PMID: 17070976

6

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.

Jordan S, Koprivica V, Chen R, Tottori K, Kikuchi T, Altar CA. Jordan S, et al. Among authors: koprivica v. Eur J Pharmacol. 2002 Apr 26;441(3):137-40. doi: 10.1016/s0014-2999(02)01532-7. Eur J Pharmacol. 2002. PMID: 12063084

7

In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.

Jordan S, Chen R, Koprivica V, Hamilton R, Whitehead RE, Tottori K, Kikuchi T. Jordan S, et al. Among authors: koprivica v. Eur J Pharmacol. 2005 Jul 11;517(3):165-73. doi: 10.1016/j.ejphar.2005.05.035. Eur J Pharmacol. 2005. PMID: 15985260

8

In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function.

Jordan S, Koprivica V, Dunn R, Tottori K, Kikuchi T, Altar CA. Jordan S, et al. Among authors: koprivica v. Eur J Pharmacol. 2004 Jan 1;483(1):45-53. doi: 10.1016/j.ejphar.2003.10.025. Eur J Pharmacol. 2004. PMID: 14709325

9

Aripiprazole protects cortical neurons from glutamate toxicity.

Koprivica V, Regardie K, Wolff C, Fernalld R, Murphy JJ, Kambayashi J, Kikuchi T, Jordan S. Koprivica V, et al. Eur J Pharmacol. 2011 Jan 25;651(1-3):73-6. doi: 10.1016/j.ejphar.2010.10.064. Epub 2010 Nov 18. Eur J Pharmacol. 2011. PMID: 21093427

10

Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.

Lau EK, Tayebi N, Ingraham LJ, Winfield SL, Koprivica V, Stone DL, Zimran A, Ginns EI, Sidransky E. Lau EK, et al. Among authors: koprivica v. Hum Genet. 1999 Apr;104(4):293-300. doi: 10.1007/s004390050957. Hum Genet. 1999. PMID: 10369158

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters